Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Allovir Inc ALVR

AlloVir, Inc. is an allogeneic T cell immunotherapy company with a focus on restoring natural immunity against life-threatening viral diseases in pediatric and adult patients with weakened immune systems. The company’s proprietary technology platforms leverage off-the-shelf, allogeneic, single- and multi-virus-specific T cells for patients with T cell deficiencies who are at risk from the life... see more

Recent & Breaking News (NDAQ:ALVR)

Alvarion (in Receivership) Receives NASDAQ Notification Related to Minimum Bid Requirement

Globe Newswire November 19, 2013

CORRECTION -- Alvarion (in Receivership) Provides Update on Company's Creditors' Plan of Settlement

Globe Newswire November 13, 2013

Alvarion (in Receivership) Provides Update on Company's Creditors' Plan of Settlement

Globe Newswire November 13, 2013

Alvarion (in Receivership) Provides Update on Status of Receivership

Globe Newswire October 24, 2013

Alvarion (in Receivership) Obtains NASDAQ Listing Extension Through January 13, 2014

Globe Newswire October 14, 2013

Alvarion (in Receivership) Receives Court Approval to Submit Creditors' Plan on October 16, 2013

Globe Newswire October 7, 2013

Alvarion (in Receivership) Provides Update on Status of Receivership

Globe Newswire September 18, 2013

Alvarion (in Receivership) NASDAQ Delisting Hearing Scheduled for October 3, 2013

Globe Newswire September 16, 2013

Alvarion (in Receivership) NASDAQ Delisting Hearing is Postponed to a Future Date

Globe Newswire September 10, 2013

Alvarion (in Receivership) Receives Court Approval for Sale to Valley Telecom

Globe Newswire September 4, 2013

Alvarion (in Receivership) Announces That the Court Granted Two Motions Regarding: Continued Operations and the Nasdaq Appeal Process

Globe Newswire September 1, 2013

Alvarion (in Receivership) Requests the Court to Approve an Improved Proposal From Valley Telecom to Acquire the Company and Its Assets

Globe Newswire August 29, 2013

Alvarion (in Receivership) Requests Court to Approve Sale of Certain Assets and Controlling Interest of the Company

Globe Newswire August 25, 2013

Alvarion (in Receivership) Requests Extension From Court to Allow the Continued Operation of the Company; NASDAQ Hearing Postponed to September 11, 2013

Globe Newswire August 22, 2013

Alvarion Ltd is Featured as the Daily Momentum Gainer to Watch on Smallcappower.com

Newsfile August 20, 2013

Alvarion (in Receivership) Provides Update on the Status of the Receivership

Globe Newswire August 2, 2013

Alvarion Receives Delisting Notification From NASDAQ

Globe Newswire July 23, 2013

Alvarion Announces Court Decision to Appoint a Receiver for the Company

Globe Newswire July 15, 2013

Alvarion Announces Board Decision Not to Oppose SVB's Request

Globe Newswire July 14, 2013

Alvarion Announces Court Decision Not to Unilaterally Enforce Liens and Appoint a Receiver With Respect to Its Assets

Globe Newswire July 11, 2013